ArticleNeuropharmacology2021

CB1 receptor neutral antagonist treatment epigenetically increases neuropeptide Y expression and decreases alcohol drinking.

Russell S Dulman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.